1.Lebenbaum M, Zaric GS, Thind A, Sarma S: Trends in obesity and multimorbidity in Canada. Prev Med 2018, 116:173–179.
2.Corscadden L, Taylor A, Sebold A, Maddocks E, Pearson C, Harvey J, Amuah JE, Walker J, Kwan A, Sommerer S et al: Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information. In.; 2011.
3.Anvari M, Lemus R, Breau R: A Landscape of Bariatric Surgery in Canada: For the Treatment of Obesity, Type 2 Diabetes and Other Comorbidities in Adults. Can J Diabetes 2018, 42(5):560–567.
4.Canadian Institute for Health Information: Bariatric Surgery in Canada. In. Ottawa, ON: CIHI; 2014.
5.Colquitt JL, Pickett K, Loveman E, Frampton GK: Surgery for weight loss in adults. Cochrane Database Syst Rev 2014(8):CD003641.
6.Huang X, Liu T, Zhong M, Cheng Y, Hu S, Liu S: Predictors of glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass: A meta-analysis, meta-regression, and systematic review. Surg Obes Relat Dis 2018, 14(12):1822–1831.
7.Li J, Lai D, Wu D: Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis. Obes Surg 2016, 26(2):429–442.
8.Panunzi S, De Gaetano A, Carnicelli A, Mingrone G: Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg 2015, 261(3):459–467.
9.Shoar S, Saber AA: Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis 2017, 13(2):170–180.
10.Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A et al: Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg 2018, 153(5):427–434.
11.de Toro-Martin J, Guenard F, Tchernof A, Perusse L, Marceau S, Vohl MC: Polygenic risk score for predicting weight loss after bariatric surgery. JCI Insight 2018, 3(17).
12.Aasbrenn M, Schnurr TM, Have CT, Svendstrup M, Hansen DL, Worm D, Balslev-Harder M, Hollensted M, Grarup N, Burgdorf KS et al: Genetic Determinants of Weight Loss After Bariatric Surgery. Obes Surg 2019.
13.Shilton H, Gao Y, Nerlekar N, Evennett N, Ram R, Beban G: Pre-operative Bariatric Clinic Attendance Is a Predictor of Post-operative Clinic Attendance and Weight Loss Outcomes. Obes Surg 2019, 29(7):2270–2275.
14.Padwal RS, Rueda-Clausen CF, Sharma AM, Agborsangaya CB, Klarenbach S, Birch DW, Karmali S, McCargar L, Majumdar SR: Weight loss and outcomes in wait-listed, medically managed, and surgically treated patients enrolled in a population-based Bariatric program: prospective cohort study. Med Care 2014, 52(3):208–215.
15.Jakobsen GS, Smastuen MC, Sandbu R, Nordstrand N, Hofso D, Lindberg M, Hertel JK, Hjelmesaeth J: Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities. JAMA 2018, 319(3):291–301.
16.Alter DA, Wijeysundera HC, Franklin B, Austin PC, Chong A, Oh PI, Tu JV, Stukel TA: Obesity, lifestyle risk-factors, and health service outcomes among healthy middle-aged adults in Canada. BMC Health Serv Res 2012, 12:238.
17.CADTH: Guidelines for the economic evaluation of health technologies: Canada. In., 4th edn. Ottawa; 2017: 19.
18.Rosella LC, Lebenbaum M, Fitzpatrick T, O’Reilly D, Wang J, Booth GL, Stukel TA, Wodchis WP: Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis. Diabet Med 2016, 33(3):395–403.
19.Weaver CG, Clement FM, Campbell NR, James MT, Klarenbach SW, Hemmelgarn BR, Tonelli M, McBrien KA, Alberta Kidney Disease N, the Interdisciplinary Chronic Disease C: Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study. Hypertension 2015, 66(3):502–508.
20.Conly J, Clement F, Tonelli M, Hemmelgarn B, Klarenbach S, Lloyd A, McAlister FA, Husereau D, Wiebe N, Au F et al: Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk. CMAJ 2011, 183(16):E1180–1188.
21.Aminian A, Daigle CR, Romero-Talamas H, Kashyap SR, Kirwan JP, Brethauer SA, Schauer PR: Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis 2014, 10(4):576–582.
22.Rishi L, Bhandari M, Kumar R: Can bariatric surgery delay the need for knee replacement in morbidly obese osteoarthritis patients. J Minim Access Surg 2018, 14(1):13–17.
23.Cazzo E, Pareja JC, Chaim EA: Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J 2017, 135(3):277–295.
24.Binda A, Jaworski P, Kudlicka E, Ciesielski A, Cabaj H, Tarnowski W: The impact of selected factors on parameters of weight loss after sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne 2016, 11(4):288–294.
25.Schwoerer A, Kasten K, Celio A, Pories W, Spaniolas K: The effect of close postoperative follow-up on co-morbidity improvement after bariatric surgery. Surg Obes Relat Dis 2017, 13(8):1347–1352.
26.Jurgensen JA, Reidt W, Kellogg T, Mundi M, Shah M, Collazo Clavell ML: Impact of Patient Attrition from Bariatric Surgery Practice on Clinical Outcomes. Obes Surg 2019, 29(2):579–584.